Nettersheim, Brunel, Sinkovits, et al. confirmed that CD4+ T cells reactive to self antigens expand poorly after vaccination and explored the mechanisms behind this effect. The differences in expansion between CD4+ T cells reactive to self antigens vs. those reactive to foreign antigens could not be explained by differences in the naive repertoires or by an enhanced Treg signature in the self-reactive CD4+ T cells. The self-reactive CD4+ T cells coexpressed CD73 and PD-1, which was found to be responsible for their limited expansion upon vaccination.
ABSTRACT: Vaccination with self- and foreign peptides induces weak and strong expansion of antigen-specific CD4(+) T cells, respectively, but the mechanism is not known. In the present study, we used computational analysis of the entire mouse major histocompatibility complex class II peptidome to test how much of the naive CD4(+) T cell repertoire specific for self-antigens was shaped by negative selection in the thymus and found that negative selection only partially explained the difference between responses to self and foreign. In naive uninfected and unimmunized mice, we identified higher expression of programmed cell death protein 1 (PD-1) and CD73 mRNA and protein on self-specific CD4(+) T cells compared with foreign-specific CD4(+) T cells. Pharmacological or genetic blockade of PD-1 and CD73 significantly increased the vaccine-induced expansion of self-specific CD4(+) T cells and their transcriptomes were similar to those of foreign-specific CD4(+) T cells. We concluded that PD-1 and CD73 synergistically limited CD4(+) T cell responses to self. These observations have implications for the development of tolerogenic vaccines and cancer immunotherapy.
Author Info: (1) La Jolla Institute for Immunology, La Jolla, CA, USA. (2) La Jolla Institute for Immunology, La Jolla, CA, USA. (3) San Diego Supercomputer Center, University of California, La
Author Info: (1) La Jolla Institute for Immunology, La Jolla, CA, USA. (2) La Jolla Institute for Immunology, La Jolla, CA, USA. (3) San Diego Supercomputer Center, University of California, La Jolla, CA, USA. (4) La Jolla Institute for Immunology, La Jolla, CA, USA. (5) La Jolla Institute for Immunology, La Jolla, CA, USA. Immunology Center of Georgia, Augusta University, Augusta, GA, USA. (6) La Jolla Institute for Immunology, La Jolla, CA, USA. (7) La Jolla Institute for Immunology, La Jolla, CA, USA. Division of Vaccine Science, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan. (8) La Jolla Institute for Immunology, La Jolla, CA, USA. Immunology Center of Georgia, Augusta University, Augusta, GA, USA. (9) Immunology Center of Georgia, Augusta University, Augusta, GA, USA. (10) La Jolla Institute for Immunology, La Jolla, CA, USA. (11) Immunology Center of Georgia, Augusta University, Augusta, GA, USA. (12) Immunology Center of Georgia, Augusta University, Augusta, GA, USA. (13) La Jolla Institute for Immunology, La Jolla, CA, USA. (14) La Jolla Institute for Immunology, La Jolla, CA, USA. (15) La Jolla Institute for Immunology, La Jolla, CA, USA. kley@augusta.edu. Immunology Center of Georgia, Augusta University, Augusta, GA, USA. kley@augusta.edu.
